3,3-Difluoro-4,4-dimethyl-pyrrolidine;hydrochloride, 98%, 500mg

2-(4-Methoxy-phenyl)-2-morpholin-4-yl-ethylamine, 250mg

2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9,9-dihexylfluorene>98.0%(HPLC)1g

2-(1H-Benzimidazol-2-yl)-4-bromophenol, 95.0%, 25g

3,5-Dimethyl-4-[(2-nitrophenyl)thio]-1H-pyrazole, 95.0%, 250mg

((3S,4R)-4-(4-Fluorophenyl)piperidin-3-yl)methanol, 95.0%, 1g

1-PYRROLIDINECARBONYLCHLORIDE, 95.0%, 1g

(2-methylbenzyl)(tetrahydro-2-furanylmethyl)amine hydrochloride, 95.0%, 1g

3-Chloro-2,6-difluoroacetophenone, 97+%, 1g

2-Chloro-5-nitrobenzenesulfonyl chloride, 95.0%, 5g

Peryodato de potasio, mínimo 99,8 %, pa, ACS, 100 g, envase de plástico.

Filtres pour seringues Minisart® NML stériles (stérilisés aux rayons gamma), 50 pièce(s)

methyl 5-bromo-1H-imidazole-2-carboxylate, 95%, 500mg